BioCentury | Sep 28, 2009
Financial News

Qiagen completes follow-on

...$20.25 Shares after offering: 226.5 million Underwriters: Deutsche Bank; Goldman Sachs; JPMorgan; Barclays Capital; Commerzbank; DZ Bank...
BioCentury | Sep 26, 2009
Top Story

Qiagen raises $556.9 million

...was $22.37. The offering was underwritten by Deutsche Bank; Goldman Sachs; JPMorgan; Barclays Capital; Commerzbank; DZ Bank...
BioCentury | Nov 1, 2006
Financial News

Biofrontera raises EUR 6.7M, lists on Duesseldorf exchange

...The shares began trading on Monday on the Duesseldorf Stock Exchange under the ticker B8F. DZ Bank...
BioCentury | Oct 16, 2006
Analyst Picks & Changes

Analyst picks & changes

...plans to acquire MYOG for $2.5B in cash (see BioCentury, Oct. 9). GPC (FSE:GPC; GPCB) DZ Bank...
...for HCV. Albuferon is expected to enter Phase III testing by year end. MorphoSys (FSE:MOR) DZ Bank...
BioCentury | Jul 3, 2006
Finance

Ebb & Flow

...raise E28.5 million ($36.7 million) by selling 1.9 million shares on Frankfurt's Prime Standard exchange. DZ Bank...
BioCentury | Jun 27, 2006
Financial News

Biofrontera planning IPO

...6. The dermatology company has not yet disclosed how much money it hopes to raise. DZ Bank...
BioCentury | Apr 28, 2006
Financial News

Evotec raises EUR $18.5 million

...7% discount to EVT's close of EUR 3.80 on Tuesday, before the deal was proposed. DZ Bank...
BioCentury | Apr 27, 2006
Financial News

Evotec proposes offering

...EUR 18 million ($22.2 million) through the sale of 5.2 million shares to institutional investors. DZ Bank...
BioCentury | Mar 30, 2006
Financial News

MorphoSys raises EUR 17.1 million

...to MOR's close of EUR 46 on Monday, before the deal was announced. WestLB and DZ Bank...
BioCentury | Mar 29, 2006
Financial News

MorphoSys proposes offering

...company MorphoSys (FSE:MOR) plans to sell 384,000 shares through a placing managed by WestLB and DZ Bank...
Items per page:
1 - 10 of 37
BioCentury | Sep 28, 2009
Financial News

Qiagen completes follow-on

...$20.25 Shares after offering: 226.5 million Underwriters: Deutsche Bank; Goldman Sachs; JPMorgan; Barclays Capital; Commerzbank; DZ Bank...
BioCentury | Sep 26, 2009
Top Story

Qiagen raises $556.9 million

...was $22.37. The offering was underwritten by Deutsche Bank; Goldman Sachs; JPMorgan; Barclays Capital; Commerzbank; DZ Bank...
BioCentury | Nov 1, 2006
Financial News

Biofrontera raises EUR 6.7M, lists on Duesseldorf exchange

...The shares began trading on Monday on the Duesseldorf Stock Exchange under the ticker B8F. DZ Bank...
BioCentury | Oct 16, 2006
Analyst Picks & Changes

Analyst picks & changes

...plans to acquire MYOG for $2.5B in cash (see BioCentury, Oct. 9). GPC (FSE:GPC; GPCB) DZ Bank...
...for HCV. Albuferon is expected to enter Phase III testing by year end. MorphoSys (FSE:MOR) DZ Bank...
BioCentury | Jul 3, 2006
Finance

Ebb & Flow

...raise E28.5 million ($36.7 million) by selling 1.9 million shares on Frankfurt's Prime Standard exchange. DZ Bank...
BioCentury | Jun 27, 2006
Financial News

Biofrontera planning IPO

...6. The dermatology company has not yet disclosed how much money it hopes to raise. DZ Bank...
BioCentury | Apr 28, 2006
Financial News

Evotec raises EUR $18.5 million

...7% discount to EVT's close of EUR 3.80 on Tuesday, before the deal was proposed. DZ Bank...
BioCentury | Apr 27, 2006
Financial News

Evotec proposes offering

...EUR 18 million ($22.2 million) through the sale of 5.2 million shares to institutional investors. DZ Bank...
BioCentury | Mar 30, 2006
Financial News

MorphoSys raises EUR 17.1 million

...to MOR's close of EUR 46 on Monday, before the deal was announced. WestLB and DZ Bank...
BioCentury | Mar 29, 2006
Financial News

MorphoSys proposes offering

...company MorphoSys (FSE:MOR) plans to sell 384,000 shares through a placing managed by WestLB and DZ Bank...
Items per page:
1 - 10 of 37